A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer
city
~31 mi. (Paso de las Limas, Mexico, +192 more cities)
facility
COI Centro Oncológico Intl. S.A.P.I. de C.V._ S.F.
biomarker
ER Positive, +1 more biomarker
drug
abemaciclib, +1 more drug
drug type
hormone therapy, +1 more type